Benjamin L. Jilek, Ph.D. - Publications

2011 Johns Hopkins University, Baltimore, MD 
Pharmacology, Molecular Biology

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Jilek BL, Zarr M, Sampah ME, Rabi SA, Bullen CK, Lai J, Shen L, Siliciano RF. A quantitative basis for antiretroviral therapy for HIV-1 infection. Nature Medicine. 18: 446-51. PMID 22344296 DOI: 10.1038/Nm.2649  0.88
2012 Sampah ME, Jilek B, Shen L, Rabi A, Zarr M, Bullen CK, Lai J, Siliciano R. Quantifying combination ARV drug effects in wild type and resistant HIV-1 infection F1000research. 3. DOI: 10.7490/F1000Research.1089961.1  0.56
2011 Sampah ME, Shen L, Jilek BL, Siliciano RF. Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance. Proceedings of the National Academy of Sciences of the United States of America. 108: 7613-8. PMID 21502494 DOI: 10.1073/Pnas.1018360108  0.88
2011 Rabi SA, O'Connell KA, Nikolaeva D, Bailey JR, Jilek BL, Shen L, Page KR, Siliciano RF, Blankson JN. Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection. Journal of Virology. 85: 979-86. PMID 21068257 DOI: 10.1128/Jvi.01721-10  0.88
2009 Wind-Rotolo M, Durand C, Cranmer L, Reid A, Martinson N, Doherty M, Jilek BL, Kagaayi J, Kizza A, Pillay V, Laeyendecker O, Reynolds SJ, Eshleman SH, Lau B, Ray SC, et al. Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1. The Journal of Infectious Diseases. 199: 1301-9. PMID 19338474 DOI: 10.1086/597759  0.88
2008 Bailey JR, O'Connell K, Yang HC, Han Y, Xu J, Jilek B, Williams TM, Ray SC, Siliciano RF, Blankson JN. Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor. Journal of Virology. 82: 7395-410. PMID 18495769 DOI: 10.1128/Jvi.00800-08  0.88
2007 McMahon MA, Jilek BL, Brennan TP, Shen L, Zhou Y, Wind-Rotolo M, Xing S, Bhat S, Hale B, Hegarty R, Chong CR, Liu JO, Siliciano RF, Thio CL. The HBV drug entecavir - effects on HIV-1 replication and resistance. The New England Journal of Medicine. 356: 2614-21. PMID 17582071 DOI: 10.1056/Nejmoa067710  0.88
Show low-probability matches.